GLP-1 Annual Cost Calculator: The Real 12-Month Price Tag

GLP-1 treatment is not a one-month commitment. Most clinicians recommend 12–18 months minimum, and many patients continue indefinitely. Understanding the full annual cost — not just the first-month price — is critical for budgeting.

Why the first month is misleading

Providers like Embody offer a compelling $149 first month, but the ongoing cost is $299/month. Over 12 months, that's $3,439 — not the $1,788 you'd calculate from the advertised price. In contrast, flat-pricing providers like GobyMeds ($99/mo) and Gala ($179/mo) charge the same amount every month regardless of dose.

12-month cost by provider (semaglutide)

The annual cost difference between the cheapest option (GobyMeds at $1,188) and a provider with dose-based pricing (Embody at $3,438) is $2,250 per year — for the same active ingredient.

Multi-year projections

For patients on maintenance therapy, the savings compound dramatically. Over 3 years at GobyMeds ($99/mo) vs a $299/mo provider, the cumulative savings exceed $7,200. At 5 years, it's over $12,000.

HSA/FSA eligibility

GLP-1 medications prescribed for a medical indication (obesity with BMI ≥30, or BMI ≥27 with a weight-related comorbidity) typically qualify for HSA and FSA spending. This effectively gives you a tax discount of 22–37% depending on your bracket. Embody specifically advertises HSA/FSA acceptance. Check with your plan administrator for specific eligibility.

⚕️ FDA Notice: Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies using FDA-approved active ingredients but are not individually reviewed by the FDA for safety, effectiveness, or quality. Always consult a licensed clinician before starting any GLP-1 therapy.